nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abivertinib, a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemia
|
Huang, Shujuan |
|
|
461 |
C |
p. 132-143 |
artikel |
2 |
Corrigendum to “β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species”. [Cancer Lett. 435 (2018) 66–79]
|
Bi, Yiming |
|
|
461 |
C |
p. 157-158 |
artikel |
3 |
Corrigendum to “Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer” [Cancer Lett. 431 (2018) 105–114]
|
Cheng, Xi |
|
|
461 |
C |
p. 156 |
artikel |
4 |
Corrigendum to “The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)” [Cancer Lett. 392 (1) (2017) 9–16]
|
Gazi, Mohiuddin |
|
|
461 |
C |
p. 155 |
artikel |
5 |
Corrigendum to “ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway” [Cancer Lett. 454 (2019) 179–190]
|
Li, Yan |
|
|
461 |
C |
p. 153-154 |
artikel |
6 |
Editorial Board
|
|
|
|
461 |
C |
p. ii |
artikel |
7 |
Endoplasmic reticulum-localized ECM1b suppresses tumor growth and regulates MYC and MTORC1 through modulating MTORC2 activation in esophageal squamous cell carcinoma
|
Yu, Valen Zhuoyou |
|
|
461 |
C |
p. 56-64 |
artikel |
8 |
Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinoma
|
Cao, Lan |
|
|
461 |
C |
p. 21-30 |
artikel |
9 |
Higd-1a regulates the proliferation of pancreatic cancer cells through a pERK/p27KIP1/pRB pathway
|
An, Hyun-Jung |
|
|
461 |
C |
p. 78-89 |
artikel |
10 |
Humanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells
|
Morita, Shinkichi |
|
|
461 |
C |
p. 144-152 |
artikel |
11 |
Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasis
|
Tonucci, Facundo M. |
|
|
461 |
C |
p. 65-77 |
artikel |
12 |
Improved anti-tumor efficacy of paclitaxel in combination with MicroRNA-125b-based tumor-associated macrophage repolarization in epithelial ovarian cancer
|
Parayath, Neha N. |
|
|
461 |
C |
p. 1-9 |
artikel |
13 |
Interference with the bromodomain epigenome readers drives p21 expression and tumor senescence
|
Webber, Liana P. |
|
|
461 |
C |
p. 10-20 |
artikel |
14 |
Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma
|
Caumanns, Joseph J. |
|
|
461 |
C |
p. 102-111 |
artikel |
15 |
Notch signaling in breast cancer: From pathway analysis to therapy
|
Krishna, B. Madhu |
|
|
461 |
C |
p. 123-131 |
artikel |
16 |
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines
|
Marampon, Francesco |
|
|
461 |
C |
p. 90-101 |
artikel |
17 |
SDHC-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS/NFκB signaling
|
Li, Jibin |
|
|
461 |
C |
p. 44-55 |
artikel |
18 |
Synthetic lethality of combined AT-101 with idarubicin in acute myeloid leukemia via blockade of DNA repair and activation of intrinsic apoptotic pathway
|
Yang, Qianying |
|
|
461 |
C |
p. 31-43 |
artikel |
19 |
The tumour microenvironment as an integrated framework to understand cancer biology
|
Burgos-Panadero, Rebeca |
|
|
461 |
C |
p. 112-122 |
artikel |